Author:
Martínez-Castellanos María Ana,Ortega-Desio Alejandro,Del Valle-Nava Fernando
Publisher
Springer International Publishing
Reference34 articles.
1. Good WV; Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 2004;102:233–48; discussion 248–50. PMID: 15747762; PMCID: PMC1280104.
2. Zhang G, Yang M, Zeng J, Vakros G, Su K, Chen M, Li H, Tian R, Li N, Tang S, He H, Tan W, Song X, Zhuang R. Shenzhen Screening for Retinopathy of Prematurity Cooperative Group. Comparison of intravitreal injection of Ranibizumab versus laser therapy for zone ii treatment-requiring retinopathy of prematurity. Retina. 2017;37(4):710–7. https://doi.org/10.1097/IAE.0000000000001241. PMID: 27529839; PMCID: PMC5388026.
3. Li Z, Zhang Y, Liao Y, Zeng R, Zeng P, Lan Y. Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP). BMC Ophthalmol. 2018;18(1):19. https://doi.org/10.1186/s12886-018-0685-6.PMID:29378530;PMCID:PMC5789737.
4. Jiang JB, Strauss R, Luo XQ, Nie C, Wang YL, Zhang JW, Zhang ZW. Anaesthesia modalities during laser photocoagulation for retinopathy of prematurity: a retrospective, longitudinal study. BMJ Open. 2017;7(1): e013344. https://doi.org/10.1136/bmjopen-2016-013344.PMID:28119385;PMCID:PMC5278276.
5. Narnaware SH, Bawankule PK, Raje D. Aggressive posterior retinopathy of prematurity (APROP): LASER as the primary modality of treatment. J Ophthalmic Vis Res. 2021;16(3):400–7. https://doi.org/10.18502/jovr.v16i3.9437.